A massage leafLET has been invented by a group of scientists at the University of California, Berkeley, to treat the symptoms of fatigue, pain, insomnia, migraines, and even asthma.
The researchers hope to eventually replace prescription painkillers for patients with these conditions.
In the meantime, the leaflet is currently undergoing a series of tests to determine whether it is effective.
The scientists’ findings were published online on February 12, 2017, in the journal Proceedings of the National Academy of Sciences.
The leaflet has been developed by Dr. Peter W. Wirth, a professor in the Department of Biological Sciences at the Berkeley Lab, and a member of the Berkeley team.
Dr. Wirt has previously published findings on a novel approach to treating asthma.
“Our hope is that we will be able to identify a specific pharmacological agent that we can use to help these people get better,” Dr. James B. Ziegler, an assistant professor in clinical pharmacology at UC Berkeley, told Fortune.
Loratidone is an alpha-1,3-adrenergic agonist that is most commonly used to treat mild to moderate asthma, but is also used to help treat chronic asthma.
It is used to relieve symptoms such as wheezing, coughs, and asthma attacks, as well as to help control certain immune responses, such as allergic reactions to pollen.
The new study also found that the leafLET was safe to use in patients with chronic asthma, who had previously had a high risk of developing asthma.
Wirdt and Zieglers research is based on the assumption that using the leaflets could help people who have developed chronic asthma to control symptoms and improve their quality of life.
They hypothesize that using Loratas pharmacological agents might help to prevent the development of new symptoms.
The team also hopes to develop a test that could detect the presence of asthma triggers, such a trigger being a common asthma symptom.
This test could help identify people who may have a high chance of developing the asthma triggers and determine if the treatment is worth it, they said.
Loratoidone, also known as loratadane, is an amino acid that is found in plants.
The study authors hope that the results from their research will lead to new research directions for Loratads development.
They hope that their results will lead other scientists to develop Loratastones, or an alternative to prescription drugs, as a new treatment option.
They also hope that this research will help to inform future research on Loratodones and other asthma drugs.
Lorataidone leaflet Source: UC Berkeley | Courtesy of UC Berkeley